Market Cap 7.80B
Revenue (ttm) 385.69M
Net Income (ttm) -287.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -74.47%
Debt to Equity Ratio 1.60
Volume 145,111
Avg Vol 529,702
Day's Range N/A - N/A
Shares Out 50.41M
Stochastic %K 70%
Beta 0.47
Analysts Strong Sell
Price Target $178.74

Company Profile

Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptak...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 332 3241
Fax: 212 320 0245
Address:
One World Trade Center, 22nd Floor, New York, United States
A_Train1
A_Train1 Dec. 24 at 7:00 PM
$AXSM biohaven failed their phase 2 for depression
0 · Reply
leonbnu
leonbnu Dec. 24 at 3:15 PM
$AXSM jpm healthcare conference is coming up in jan, guess we will hear about axs-05 very soon.
1 · Reply
JeffTex
JeffTex Dec. 24 at 3:04 PM
$AXSM so if we hv another Gov shutdown in 6 weeks. Will that effect approval timeline on 05 or others in pipeline
0 · Reply
11thestate
11thestate Dec. 24 at 1:56 PM
$AXSM has agreed to settle with investors over claims that it misled them about regulatory risks related to its migraine drug AXS-07. Who’s eligible? Anyone who purchased $AXSM shares between December 30, 2019 and April 22, 2022. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.46 — but if only ~25% of eligible investors file, the effective payout could increase to $1.84. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/axsome-investor-settlement
0 · Reply
Vakeshka
Vakeshka Dec. 24 at 1:50 PM
$AXSM only Axsome and the FDA know exactly. I'm just keeping fingers crossed it's not an RTF and the company is just waiting to release the news on a day that minimizes negative impact, e.g. Dec 26th, Friday after Christmas. As long as the FDA accepts the package, +- couple of months to the timeline shouldn't move the needle for long-term investors.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 24 at 1:45 PM
Enter: $AXSM Calls Strike Price: $160 Expiry Date: JAN 16 2026 Buy in Price: $3.47 - $3.64 Sell Price: $7.29 Profit : +110% (Turn every $1 into $2.10) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
WAJeff
WAJeff Dec. 24 at 12:11 AM
$AXSM Brief spike to $158.56 ath today
0 · Reply
CanadianMoneyMaker
CanadianMoneyMaker Dec. 23 at 9:38 PM
$AXSM not sure if anyone wants to hear this but this statement on nov 7th by HT states “we recently submitted our supplemental NDA for AXS-05 for the treatment of Alzheimer disease agitation” The question we are all thinking…..what does “recently” refer to. I’m thinking the snda was submitted around the 3rd week of October. The first two weeks the fda I don’t believe was accepting ndas. So here we are again. Counting days. 60days from October 20th was last Friday… 🤦‍♂️ 🤯
4 · Reply
JeffTex
JeffTex Dec. 23 at 4:34 PM
$AXSM posted on yahoo board. Cmon HT throw us a bone 🦴 tomorrow & get us over $160+
0 · Reply
mrp1780786
mrp1780786 Dec. 23 at 3:48 PM
$AXSM personally I think the surge was to sell some option contracts.. 😏😂😂
0 · Reply
Latest News on AXSM
Axsome: Some Recent Setbacks, Some Recent Wins -- Still A Buy

Jul 25, 2025, 1:46 PM EDT - 5 months ago

Axsome: Some Recent Setbacks, Some Recent Wins -- Still A Buy


Axsome Therapeutics Clocks Around 60% Topline Growth In Q1

May 5, 2025, 10:41 AM EDT - 8 months ago

Axsome Therapeutics Clocks Around 60% Topline Growth In Q1


Axsome: The Alzheimer's Agitation Program For AXS-05

Mar 21, 2025, 11:36 AM EDT - 9 months ago

Axsome: The Alzheimer's Agitation Program For AXS-05


Axsome Q4 Earnings: Revenues Rising, Skepticism Lingering

Feb 20, 2025, 8:15 AM EST - 10 months ago

Axsome Q4 Earnings: Revenues Rising, Skepticism Lingering


Axsome Therapeutics, Inc. (AXSM) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 11:12 AM EST - 11 months ago

Axsome Therapeutics, Inc. (AXSM) Q4 2024 Earnings Call Transcript


US FDA approves Axsome Therapeutics' migraine drug

Jan 30, 2025, 3:55 PM EST - 11 months ago

US FDA approves Axsome Therapeutics' migraine drug


A_Train1
A_Train1 Dec. 24 at 7:00 PM
$AXSM biohaven failed their phase 2 for depression
0 · Reply
leonbnu
leonbnu Dec. 24 at 3:15 PM
$AXSM jpm healthcare conference is coming up in jan, guess we will hear about axs-05 very soon.
1 · Reply
JeffTex
JeffTex Dec. 24 at 3:04 PM
$AXSM so if we hv another Gov shutdown in 6 weeks. Will that effect approval timeline on 05 or others in pipeline
0 · Reply
11thestate
11thestate Dec. 24 at 1:56 PM
$AXSM has agreed to settle with investors over claims that it misled them about regulatory risks related to its migraine drug AXS-07. Who’s eligible? Anyone who purchased $AXSM shares between December 30, 2019 and April 22, 2022. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.46 — but if only ~25% of eligible investors file, the effective payout could increase to $1.84. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/axsome-investor-settlement
0 · Reply
Vakeshka
Vakeshka Dec. 24 at 1:50 PM
$AXSM only Axsome and the FDA know exactly. I'm just keeping fingers crossed it's not an RTF and the company is just waiting to release the news on a day that minimizes negative impact, e.g. Dec 26th, Friday after Christmas. As long as the FDA accepts the package, +- couple of months to the timeline shouldn't move the needle for long-term investors.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 24 at 1:45 PM
Enter: $AXSM Calls Strike Price: $160 Expiry Date: JAN 16 2026 Buy in Price: $3.47 - $3.64 Sell Price: $7.29 Profit : +110% (Turn every $1 into $2.10) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
WAJeff
WAJeff Dec. 24 at 12:11 AM
$AXSM Brief spike to $158.56 ath today
0 · Reply
CanadianMoneyMaker
CanadianMoneyMaker Dec. 23 at 9:38 PM
$AXSM not sure if anyone wants to hear this but this statement on nov 7th by HT states “we recently submitted our supplemental NDA for AXS-05 for the treatment of Alzheimer disease agitation” The question we are all thinking…..what does “recently” refer to. I’m thinking the snda was submitted around the 3rd week of October. The first two weeks the fda I don’t believe was accepting ndas. So here we are again. Counting days. 60days from October 20th was last Friday… 🤦‍♂️ 🤯
4 · Reply
JeffTex
JeffTex Dec. 23 at 4:34 PM
$AXSM posted on yahoo board. Cmon HT throw us a bone 🦴 tomorrow & get us over $160+
0 · Reply
mrp1780786
mrp1780786 Dec. 23 at 3:48 PM
$AXSM personally I think the surge was to sell some option contracts.. 😏😂😂
0 · Reply
pi22dv7
pi22dv7 Dec. 23 at 3:04 PM
$AXSM Wowazie Axsome RollerCoaster :-)
0 · Reply
Mike826_1999
Mike826_1999 Dec. 23 at 12:21 PM
$AXSM In recent months Axsome has seen a uptick in press coverage, reflecting and increasing broader investor interest. The information in these articles is nothing new to us; however, each one increases public awareness of Axsome’s potential. Here’s another one with nothing new to those who follow Axsome every day but eye opening to the uninformed. https://www.directorstalkinterviews.com/axsome-therapeutics-inc-axsm-stock-analysis-strong-buy-ratings-signal-17-75-potential-upside/4121231775
0 · Reply
Live2ride
Live2ride Dec. 22 at 8:40 PM
$AXSM Dear Santa, all I want for Christmas is a 05 priority review and a 10 million share volume day to squeeze the shorts. Oh, and a Red Ryder bb gun.
2 · Reply
Vakeshka
Vakeshka Dec. 22 at 8:01 PM
$AXSM I think this is from a couple of days ago. In a report released today, Jefferies maintained a Buy rating on Axsome Therapeutics, with a price target of $200.00
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 22 at 7:48 PM
Enter: $AXSM Calls Strike Price: $155 Expiry Date: JAN 16 2026 Buy in Price: $5.95 - $7.30 Sell Price: $9.70 Profit : +63% (Turn every $1 into $1.63) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Uncle_Baby_Billy
Uncle_Baby_Billy Dec. 22 at 4:31 PM
$AXSM Nice to see Axsome mentioned here: https://www.biospace.com/business/with-biotech-back-analysts-make-their-picks-for-2026?utm_campaign=Newsletter%20%7C%20GenePool&utm_medium=email&_hsenc=p2ANqtz-8EANzDDls0LzSQXw4IY34rn-AZ2lsSFiW4PED3zrycC4jUqKbStU6LeTgXpulijs3M66-dsa7udvQAXh5FewUsj7MwkA&_hsmi=395617405&utm_content=395617405&utm_source=hs_email
0 · Reply
learningcurves
learningcurves Dec. 22 at 3:14 PM
0 · Reply
JeffTex
JeffTex Dec. 22 at 2:36 PM
$AXSM well while we twiddle our fingers. What are best guesses when we BE
1 · Reply
11thestate
11thestate Dec. 22 at 2:01 PM
$AXSM has agreed to settle with investors over claims that it misled them about regulatory risks related to its migraine drug AXS-07. Who’s eligible? Anyone who purchased $AXSM shares between December 30, 2019 and April 22, 2022. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.46 — but if only ~25% of eligible investors file, the effective payout could increase to $1.84. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/axsome-investor-settlement
1 · Reply
1iquid
1iquid Dec. 22 at 4:30 AM
💎 Liquid® Live Actionable Trade Asset: $AXSM Contracts: $AXSM January 15, 2027 $155 Calls Scale in: $25.76- $31.48 Scale out: $100.17-$171.72 Profit Potential : 126% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
JeffTex
JeffTex Dec. 22 at 2:25 AM
$AXSM Avuelty commercial now on Prime Time tonight during Rob Reiner Tribute !
2 · Reply
MagicPills
MagicPills Dec. 21 at 10:54 PM
$AXSM Symbravo IQVIA reporting : IQVIA reporting 1,147 TRxs/687 NRxs (+12%/ +24% w/w) for the week ending Friday, December 12, 2025 (Week 27 of the Symbravo launch), comparing to last week's 1,026 TRxs/555 NRxs for Symbravo. Thanks to ‘Dough’ for providing the numbers on X.
1 · Reply